Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib Phase 2 in Active RA
NCT00902486Phase 2Completed
- Sponsor
- Incyte
- Start
- May 2009
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of baricitinib in rheumatoid arthritis (RA), sponsored by Incyte. Started May 2009; status: completed.
02
Drugs
baricitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00902486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902486.